The cancer stem cell (CSC) theory predicts that a fraction of cancer cells possess unique self-renewal properties that mediate tumor initiation and propagation. 1 Consistent with this theory, several cell subpopulations have been identified by either cell surface markers or enzymatic activities as CSCs in solid tumors. Previous studies demonstrated the CSC's drug resistance, [2] [3] [4] self-renewal characteristics and tumor-initiating properties in xenograft mouse models. [5] [6] [7] [8] [9] In lung cancer, three different marker-defined CSC populations have been identified: drug-resistant side population (SP), 3, 10 CD133 pos cells 2, 11 and ALDH high cells. 12, 13 SP cells isolated from nonsmall cell lung adenocarcinoma (NSCLA) cell lines had higher expression of ABC transporters and were resistant to chemotherapeutic drugs. 3 We previously showed that NSCLA SP cells were more metastatic in xenograft models and the invasive behavior of SP cells was driven by high Rac1 activity. 10 Drug-resistant cells derived from NSCLA cell lines were enriched for CD133 pos cells and displayed elevated cytokine expression. 11 NSCLA cells with higher ALDH activity were more tumorigenic, with elevated notch1 signaling driving the tumor-initiating activity. 13 However, the relationship between these different marker-defined cancer stem/progenitor cell (CS/PCs), that is, whether they represent overlapping, stochastic or hierarchical subpopulations of NSCLA, has not been established.
Advancement of CSC theory has led to the proposal that targeting CSCs may eradicate residual chemoradiation therapy-resistant tumor cells in patients. Consequently, Gupta et al.
14 suggested that induced CSC differentiation by salinomycin can block mammary CSC activity and metastasis, although the efficacy of such reagents remained untested in preclinical and clinical solid tumor models. Several recent reports propose that CSCs and non-CSCs can exhibit plasticity and interconvert in nature. 15, 16 Epithelial-mesenchymal transition (EMT) was proposed as one of the underlying mechanisms for CSC generation in breast cancer. 17 Whether such properties observed in breast cancer translate to lung cancer remains unclear.
Identifying mechanisms involved in lung CSC regulation may help develop novel, effective cancer therapies. Using NSCLA cell lines and primary patient samples, we demonstrate that the SP, CD133 pos Figure S1A) , whereas H441 cells expressed 18-30% CD24 low with undetectable CD44. Further, we isolated cells from primary NSCLA tumor samples and cultured them in non-adherent sphere-forming conditions. These cells have a cobble-stone epithelial morphology in adherent culture. After 1 week in sphere-forming conditions, primary NSCLACs contain 80%
CD133
pos and 2% SP cells (Figure 1b , left panel). Interestingly, when cells were cultured in adherent culture conditions for an additional 1 or 3 weeks, the CD133 pos subpopulation decreased to either 20% or 2%, respectively, whereas the SP subpopulation increased to 8-10% and 15-18%, respectively (Figure 1b middle and right panels, respectively), suggesting the various marker-defined subpopulations of CS/PC transition dynamically.
We sought to determine the potential overlap of these different marker-defined CS/PCs in NSCLA cells. We performed FACS analysis on SP and non-SP cells to determine the expression of CD133 or ALDH. We observed minimal overlap between SP and CD133 pos ( Figure 1c ) and between SP and ALDH high ( Figure 1d Recent studies suggest that CSCs may serve as the 'seeds' for tumor metastasis at the secondary site. 18, 19 We therefore examined the expression of metastasis-associated genes in different CS/PC subpopulations. SP cells from primary NSCLA cells had increased expression of CXCR4, HoxB9, TGFb1, VEGFA and IL-6 compared with non-SP cells EMT differentially regulates different marker-defined CS/ PC subpopulations. In breast cancer cells, EMT promotes CSC transition. 17 To examine the role of EMT in the plasticity of NSCLA CS/PC, we treated A549, H441 and primary NSCLA cells with TGFb1 to induce EMT. Figure S3B) . The dynamic nature of TGFb1-induced EMT was previously described, [20] [21] [22] and we observed a similar time course in correlation between morphologic changes and EMT markers gene expression.
Next, we examined the effect of EMT on expression of various CS/PC markers. TGFb1 treatment increased CD133 pos and ALDH high subpopulations in A549 cells (Figures 5a and b, respectively) Figure S4A) , whereas TGFb1 withdrawal decreased the population of CD24 low CD44 high cells. We further tested the effect of EMT on the SP subpopulation of CSCs. Surprisingly, TGFb1 treatment abolished SP cells in A549 (Figure 5c EMT induces self-renewal, metastatic gene expression and the CS/PC activity. With differential effects of EMT on various CS/PC subpopulations, we examined the role of EMT on CS/PC activity by assessing the self-renewal gene expression pattern after TGFb1 treatment. TGFb1 treatment increased oct4, nanog and notch1 expression compared with untreated cells (Figure 6a ), whereas the self-renewal gene expression was reversed to control levels upon the withdrawal of TGFb1 (Supplementary Figure S8) . We observed a close correlation between the morphological changes during EMT process and self-renewal gene expression. Consistent with the EMT promoting self-renewal gene expression, we found a significant increase in sphere-forming activity in TGFb1-treated H441 and primary NSCLA cells (Figure 6b , left and right panels, respectively). Concomitantly, TGFb1 treatment also increased the expression of several metastatic genes including HoxB9, TGFb1, VEGFA, IL-1b and IL-6 (Figure 6c) , and enhanced lung colonization activity (Figure 6d ). These results indicate that EMT can serve as a mechanism of plasticity in defined subpopulations of CS/PCs promoting tumor initiation and metastasis. Interestingly, TGFb1-treated cells appeared more prone to liver tumor development in mice similar to ALDH high cells (data not shown). However, because these xenografts were generated through intra-venous injection, we cannot determine if the liver tumors were derived from lung metastasis or from liverlodged cancer cells.
Rac1 targeting blocks EMT and inhibits CS/PC activities.
Rac1 is a critical regulator of cell cytoskeletal organization and transcriptional regulation. As EMT involves distinct morphological and transcription alterations, we wanted to determine whether Rac1 is involved in the NSCLA EMT process. We previously showed that Rac1 regulates cell adhesion, migration and lung colonization, and is required for metastasis of NSCLA cells. 10 TGFb1 treatment increased active Rac1-GTP level in A549 cells reversibly, consistent with the transient nature of TGFb1 on EMT (Figure 7a ). Rac1 knockdown mediated by shRNA blocked the actincytoskeletal restructuring during EMT (data not shown). Rac1 knockdown was able to block the EMT gene signature changes such as E-cadherin reduction and Snail enhancement (Figure 7b left and right panels, respectively) . Accompanying the blockade of EMT by Rac1 knockdown, we observed a significant decrease in sphere-forming activity (Supplementary Figure S9) and decrease in lung colonization by H441 (data not shown) and primary NSCLA cells. These changes initiated by Rac1 suppression improved the survival of xenograft mice (Figure 7c ). NSC23766, a Rac inhibitor, decreased Rac1 activity in A549 cells ( Figure 7d) ; consequently, partially blocked TGFb1-induced EMT determined by marker gene expressions (Figure 7e) . Further, NSC23766 inhibited the TGFb1-induced changes in CS/PC subpopulations, that is, a decrease in SP cells (Figure 7f, left panel) and an increase in ALDH high cells (Figure 7f, right panel) . Therefore, Rac1 constitutes a potential target in suppressing EMT-associated CS/PC plasticity.
Discussion
This study demonstrates that drug-resistant SP cells represent a phenotypically distinct CS/PC subpopulation from several other CS/PC subpopulations including CD133 pos , ALDH high or CD24 low CD44 high cells in NSCLA cells. The CS/PC subpopulations are plastic, and non-CS/PCs can convert to CS/PCs under defined conditions. One possible mechanism for the dynamic transition, EMT, can differentially regulate various CS/PC subpopulations and promotes a net increase of CS/PC activity in vitro and in vivo. Our work implies that the elimination of one CS/PC subpopulation may be insufficient for cancer eradication, because other CS/PC subpopulations, as well as plastic conversion of non-CS/PCs, could potentially propagate tumors. Thus, effective inhibition of CS/PC activity and the dynamic conversion of non-CS/PCs to CS/PCs may be necessary to achieve NSCLA eradication. To this end, we show that Rac1 GTPase, an EMT regulator, may be a useful target for suppressing multiple subpopulations of CS/PCs and CS/PC plasticity.
Clinical observations of secondary metastasis developing post-surgery or chemotherapy have spawned the hypothesis that these metastases are derived from a therapy-resistant tumor cells. CSC theory (reviewed in Shackleton et al. Targeting Rac1 in lung cancer stem progenitor cell plasticity S Akunuru et al the lung, where normal stem/PC hierarchy remains unclear, it is difficult to assess whether lung adenocarcinomas fit the CSC or clonal selection model of tumor progression. In our current study, increased lung colonization and expression of metastasis-associated genes in different NSCLA CS/PC subpopulations correspond with higher metastatic potential of CS/PCs. Previous lung CSC studies 2, 3, 11, 13 focused on single CS/PC subpopulations without examining other distinct CS/PC subpopulations that might or might not share the characterized properties. As we observed minimal overlap between various NSCLA CS/PC subpopulations, two possibilities remain. First, the CS/PC subpopulations examined might represent a plastic pool of cancer progenitors, not bona fide CSCs. Second, lung CSCs might express multiple CSC markers but a truly identifying marker combination remains unknown.
Drinks et al. 28 discussed CSC plasticity and postulated that the unstable genomic environment in cancer cells might readily facilitate reprogramming from differentiating cancer cells to CSCs, unlike the hurdle of differentiated cells reprogramming into induced pluripotent stem cells. Boiko et al. 27 reported CD271 þ CSC marker in human melanoma, with CD271
À cells displaying slower tumor growth in human skin grafts in immunodeficient mice. However, the CD271 À cells derived from in vitro or in vivo cultured patient cells resulted in increased tumorigenic potential. CSC plasticity was also supported by studies of Roesch et al. 15 22 Interestingly, our observed self-renewal gene increase correlates with the findings that oct4 and nanog overexpression induces EMT in NSCLA cells. 31 Furthermore, our observed increase in IL6 expression by TGFb1 treatment in CS/PCs corroborates with another report, where TGFb1 was shown to induce EGFR inhibitor resistance in H1650 lung adenocarcinoma cells mediated by IL6. 32 However, our approach using primary NSCLA samples to confirm our cell line-based observations strengthens the pathological relevance of the conclusions in understanding the chemoresistant lung cancer cells.
We observed an increase in IL1b expression after TGFb1 treatment. It is possible that TGFb1 regulates expression of cytokines including IL1b through the NF-kb pathway. In keratinocytes, Snail, through its RelA domain activity, can regulate NF-kb activity and modulate cytokine expression. 23 Similarly, IL6 is increased in all CS/PC subpopulations and TGFb1-treated cells, which could serve as a common signaling axis contributing to CS/PC metastasis. Previously, increased IL6 expression was associated with EMT induced either by TGFb1 or Snail/Zeb1 in H358 lung adenocarninoma cells. 24 In human trabecular meshwork cells, TGFb1 was shown to induce IL6 expression and secretion. 25 Interestingly, IL6 overexpression in breast adenocarcinoma cells resulted in a 5-7-fold increase in lung metastases in xenograft models. 26 Based on these observations, it is possible that increased IL6 expression downstream of TGFb1 is involved in lung adenocarcinoma metastasis.
Among the potential molecular pathways regulating CS/PC plasticity, we found Rac1 GTPase, a tractable candidate critical for the EMT-mediated non-CS/PC to CS/PC transition. Rac1, together with RhoA, has an important role in EMT, during which cells undergo profound morphological changes and acquire a migratory phenotype. 33 An active isoform of Rac1, Rac1b, has been shown to mediate EMT and ROS production, 34 and more recently Rac1 was shown to regulate TGFb1-mediated EMT and MMP9 production in transformed keratinocytes. 35 Our finding that Rac1 inhibition can block EMT-mediated changes in CS/PCs raises an intriguing idea that targeting Rac1 signaling might present a novel therapeutic strategy for reducing CS/PC plasticity, in addition to suppressing CS/PC activity by inhibiting the cell cycle progression of CS/PC self-renewal process. 10 The impact of such a concept on cancer therapeutics will await further validation in in vivo conditions where dynamic changes may constantly favor CS/PC selection and progression.
Materials and Methods
Cell culture. A549 and H441 cells were cultured according to ATCC guidelines. Primary patient lung adenocarcinoma samples were obtained with written consent from patients under an approved Institution Review Board protocol by the University of Cincinnati Scientific Review Committee (IRB no. 01-09-27-07), and were used in the experiments according to the Cincinnati Children's Hospital Medical Center Scientific Review Committee (IRB no. 07-06-57) that the identity of the patients remains anonymous. Detailed methods are described in Supplementary Materials section.
SP, ALDH and CD133 cell analysis and isolation. Cells were either stained with Hoechst 33342 staining buffer for SP as described previously 36 Rac1-GTP pull-down assay. To perform Rac1 pull-down assays, cells were lysed by adding lysis buffer (20 mM Tris HCl pH 7.6, 100 mM NaCl, 10 mM MgCl, 1% Triton X-100, 0.2% SDS) with protease and phosphatase inhibitors directly to adherent cells as described previously. 37 The lysates are incubated with bead-immobilized P21-binding domain of a downstream effector protein, PAK1. After washes, Rac1-GTP bound to the beads and total lysates are loaded into parallel gels to reveal relative Rac1-GTP and Rac1 contents by anti-Rac1 western blotting. GAPDH was probed in the total lysates to ensure equal loading.
Lung colonization assay. Use of mice as xenograft hosts was approved by the IACUC committee at the Cincinnati Children's Hospital Medical Center (Protocol no. 8D06052). Specified number of cells were suspended in PBS and injected intravenously into immune compromised NOD/SCID/gc À / À (NSG) mice by tail vein injection. At the end of the study, lungs were fixed in Bouin's solution to count the number of tumors.
Statistics. Statistical analysis was performed either by Student's t-test or two-way ANOVA Bonferroni test.
